Keybanc has decided to maintain its Underweight rating of Pinnacle West Capital (NYSE:PNW) and lower its price target from $64.00 to $62.00.
Shares of Pinnacle West Capital are trading down 0.02% over the last 24 hours, at $69.92 per share.
Pinnacle West Capital (NYSE:PNW) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:40 AM.
Here's what investors need to know about the announcement.
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Credit Suisse analyst Nicholas Campanella initiates coverage on Pinnacle West Capital (NYSE:PNW) with a Underperform rating and announces Price Target of $73.